Cryomass Technologies

Cryomass Technologies Current Liabilities

Current Liabilities of Cryomass Technologies (CRYM) as of Nov 19, 2026.

Current Liabilities

-USD

Last updated:

Current Liabilities of Cryomass Technologies is 2026 - USD. Current Liabilities of Cryomass Technologies was 2025 - USD. It decreases by % lower compared to the previous year.

The Cryomass Technologies Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2010
440,000.00 USD
Jan 1, 2011
440,000.00 USD
Jan 1, 2012
420,000.00 USD
Jan 1, 2013
500,000.00 USD
Jan 1, 2014
780,000.00 USD
Jan 1, 2015
80,000.00 USD
Jan 1, 2016
120,000.00 USD
Jan 1, 2017
131,021.00 USD
The Cryomass Technologies Current Liabilities history
YEARCurrent LiabilitiesYoY
131,021.00USD+9.18%
120,000.00USD+50.00%
80,000.00USD-89.74%
780,000.00USD+56.00%
500,000.00USD+19.05%
420,000.00USD-4.55%
440,000.00USD-0.00%
440,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

On Eulerpool you can find the complete historical development of Current Liabilities Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Cryomass Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cryomass Technologies

All Key Metrics — Cryomass Technologies